Omaciclovir

N/A

Report date: 2022/12/07 17:07:50
NME

Base Information

Drug NameOmaciclovir
Drug Alias Name奥马洛韦omaciclovirum(-)-2HM-HBGA-1820912-HMHBG +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman herpesvirus 1 DNA polymerase inhibitorsHuman herpesvirus 5 DNA polymerase inhibitors
TargetsHuman herpesvirus 1 DNA polymeraseHuman herpesvirus 5 DNA polymerase
Therapy Area/IndicationsHerpesviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKarolinska InstitutetMedivir AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesMedivir ABKarolinska Institutet
Active IndicationsN/A
Inactive IndicationsHerpesviridae Infections

Other Information

ATC CodeN/A
Related LinksKEGG